Press Release
Global Plastics in Personalized Drug Delivery Market to Reach USD 2.65 B by 2035
Pune, December 30, 2025
The global plastics market tailored for personalized drug delivery systems is witnessing a dynamic expansion, with its valuation projected to grow from approximately USD 1.12 billion in 2024 to around USD 2.65 billion by 2035, according to a recent study by Global Data Route Analytics. This upward trend represents a robust compound annual growth rate (CAGR) of 11.1%, driven by technological advancements in healthcare and the increasing adoption of patient-specific therapies.
For a free sample of the report, please contact us here:
Material Science Empowering Personalized Therapies
With growing emphasis on patient-centric care and minimally invasive procedures, materials such as biodegradable plastics, biocompatible polymers, elastomers, thermoplastics, and composites are becoming crucial in the design and development of advanced drug delivery systems. These materials ensure compatibility, safety, and adaptability—key attributes in the evolving drug delivery landscape.
For any inquiry related to this report, please click here:
Expanding Applications Across Devices and Industries
The market covers a range of applications such as:
- Implantable drug delivery devices
- Injectable systems
- Transdermal patches
- Oral drug delivery
- Inhalation devices
End-use industries include pharmaceuticals, biotechnology companies, medical device manufacturers, and R&D institutes, each contributing to the development of more effective and personalized treatment modalities.
For discounts related to this report, explore here:
Key Players Leading Innovation
Leading companies operating in this market include:
- Evonik Industries AG
- BASF SE
- Lubrizol Corporation
- Mitsubishi Chemical Holdings Corporation
- Covestro AG
- Celanese Corporation
- PolyOne Corporation
- Avery Dennison Corporation
- 3M Company
- DSM N.V.
- Sartorius AG
- West Pharmaceutical Services, Inc.
- Integra LifeSciences Holdings Corporation
- Trelleborg AB
These players are investing in next-gen materials and forming strategic partnerships to advance drug efficacy and delivery customization.
Global Reach
The market analysis spans regions including North America, Europe, Asia-Pacific, Middle East & Africa, and South America, reflecting a truly global demand for customized and material-optimized drug delivery systems.
About Global Data Route Analytics
Global Data Route Analytics is a market research and consulting firm that provides businesses with data analysis, market forecasts, and tailored reports across various industries. The company uses advanced data analysis techniques, proprietary data, and an expert team to help clients understand market trends, make informed decisions, and develop strategies. They focus on delivering customized solutions, competitive intelligence, and growth strategies to help businesses succeed in their respective markets.
Media Contact:
Srushti Tungar
Global Data Route Analytics